Two firms act as Australian medicinal cannabis company makes Canadian acquisition

The deal is the ASX-listed company’s first foray into extraction and manufacturing of cannabis-infused products

Two firms act as Australian medicinal cannabis company makes Canadian acquisition

Two firms have acted in Australia as an ASX-listed medicinal cannabis company makes and acquisition in Canada.

DLA Piper acted as Australian and Canadian counsel to Althea, which has agreed to acquire Peak Processing Solutions, its first foray into extraction and manufacturing of cannabis-infused products. The firm also advised on Althea’s associated $30m capital raising, though exact financial details of the acquisition itself were not disclosed.

Russell Kennedy acted for the founders of Peak Processing as Australian counsel. The firm said it received instructions from Torkin Manes, the Canadian counsel for Peak Processing, through Ally Law Alliance.

DLA Piper fielded a cross-border team to act on the deal. The team was headed by Melbourne-based corporate and projects partner Chris Mitchell, who recently joined the firm. He was supported in Australia by senior associates Dylan Burke and Simone Lim, and solicitors Chanel Mercurio and Tara Alexander.

In Canada, the DLA Piper team included corporate partner Robert Fonn, finance partner Ilia Danef, tax partner Kevin Fritz, counsel Nicole Kapos and associate Christopher Pejovic.

Mitchell said that the deal allows Althea to expand its current business portfolio into the Canadian recreational market. To ensure the deal succeeded, DLA Piper tapped its experts in equity capital markets, M&A, regulatory, and the North American cannabis industry, he said.

The Russell Kennedy team was led by special counsel Rory Maguire and principal Andrew Parlour. They were assisted by associate Stephanie Quatela.

Maguire said that the deal is particularly significant given new regulations covering cannabis in Canada. Earlier this month, Health Canada started accepting applications for companies seeking to produce cannabis-derived products, including edibles, beverages, and vaping goods.

Althea, which operates in Australia and the UK, plans to expand in emerging markets in Europe and Asia. It listed last year on the ASX, counselled by Norton Rose Fulbright.

Recent articles & video

Maddocks assists CleanPeak Energy on its acquisition of three solar farms

NSW introduces amendments to strengthen laws on serious strangulation offences

Freshfields unveils Data Trends 2024 report, forecasting challenges and AI opportunities

Holding Redlich appoints seasoned investment funds star as new partner

New report highlights critical need to boost legal aid funding

Fast Firms of 2023 are at the forefront of tech advancements

Most Read Articles

Clayton Utz launches e-learning hub for FAR Bill 2023 compliance

WFW Sydney partner recognised in global LGBTQ+ executives list

SA Supreme Court upholds decision to eject tenant due to failure to keep premises clean

Victorian barrister appointed as new Commonwealth Director of Public Prosecutions